Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: BJU Int. 2010 Nov 24;108(5):693–699. doi: 10.1111/j.1464-410X.2010.09900.x

TABLE 2. Numbers and percentages of patients who had stage pT0 at cystectomy and numbers and percentages of patients whose pT0 status was not known, by treatment–histology combinations.

Histological type Treatment arm N No. (%) with pT0 No. (%) with pT0 status unknown
Mixed tumours MVAC + cystectomy 32 11 (34) 4 (13)
Mixed tumours Cystectomy alone 27 1 (4) 3 (11)
Pure UC MVAC + cystectomy 115 33 (29) 15 (13)
Pure UC Cystectomy alone 121 17 (14) 7 (6)

UC, urothelial carcinoma; MVAC, methotrexate, vinblastine, doxorubicin and cisplatin.